A versatile equation to describe reversible enzyme inhibition and activation kinetics: Modeling β-galactosidase and butyrylcholinesterase

Biochimica et Biophysica Acta - General Subjects

Volumn 1770, Issue 5, 2007, Pages 733-746

  Walsh, Ryan ^a   Martin, Earl ^b   Darvesh, Sultan ^a,b  

^a DALHOUSIE UNIVERSITY   (Canada)

^b MOUNT SAINT VINCENT UNIVERSITY   (Canada)

Author keywords

Alzheimer's disease; Enzyme kinetics; Equation modeling; Galantamine; Global data fitting; Homocysteine thiolactone; Vascular disease

Indexed keywords

BETA GALACTOSIDASE; CHOLINESTERASE; CHOLINESTERASE INHIBITOR; HOMOCYSTEINE THIOLACTONE; IMIDAZOLE;

ALZHEIMER DISEASE; ARTICLE; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME ACTIVATION; ENZYME ANALYSIS; ENZYME INHIBITION; ENZYME KINETICS; ENZYME REGULATION; ENZYME SUBSTRATE COMPLEX; HUMAN; MATHEMATICAL MODEL; MICHAELIS MENTEN KINETICS; MOLECULAR MODEL; NONHUMAN; PRIORITY JOURNAL; VASCULAR DISEASE;

ALZHEIMER DISEASE; BETA-GALACTOSIDASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; DATA INTERPRETATION, STATISTICAL; ENZYME ACTIVATION; HYPERHOMOCYSTEINEMIA; KINETICS; MATHEMATICS;

EID: 33947112918     PISSN: 03044165     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbagen.2007.01.001     Document Type: Article

References (35)

1. Whitehouse P.J., Price D.L., Clark A.W., Coyle J.T., and DeLong M.R. Alzheimer disease: evidence for selective loss of cholinergic neurons in the nucleus basalis. Ann. Neurol. 10 (1981) 122-126
2. Bartus R.T., Dean R.L., Beer B., and Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction. Science 217 (1982) 408-417
3. Coyle J.T., Price D.L., and DeLong M.R. Alzheimer's disease: a disorder of cortical cholinergic innervation. Science 219 (1983) 1184-1190
4. Birks J. Cholinesterase inhibitors for Alzheimer's disease. Cochrane Database of Syst. Rev. (2006) 10.1002/14651858 (Issue 1. Art. No.: CD005593)
5. Darvesh S., Walsh R., and Martin E. Homocysteine thiolactone and human cholinesterases. Cell. Mol. Neurobiol. 27 (2007) 33-48
6. Darvesh S., Grantham D.L., and Hopkins D.A. Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation. J. Comp. Neurol. 393 (1998) 374-390
7. Greig N.H., Lahiri D.K., and Sambamurti K. Butyrylcholinesterase: an important new target in Alzheimer's disease therapy. Int. Psychogeriatr. 14 (2002) 77-91
8. Mesulam M.-M., Guillozet A., Shaw P., Levey A., Duysen E.G., and Lockridge O. Acetylcholinesterase knockouts establish central cholinergic pathways and can use butyrylcholinesterase to hydrolyze acetylcholine. Neuroscience 110 (2002) 627-639
9. Darvesh S., Hopkins D.A., and Geula C. Neurobiology of butyrylcholinesterase. Nat. Rev. Neurosci. 4 (2003) 131-138
10. Darvesh S., and Hopkins D.A. Differential distribution of butyrylcholinesterase and acetylcholinesterase in the human thalamus. J. Comp. Neurol. 463 (2003) 25-43
11. McCaddon A., Hudson P., Davies G., Hughes A., Williams J.H., and Wilkinson C. Homocysteine and cognitive decline in healthy elderly. Dement. Geriatr. Cogn. Disord. 12 (2001) 309-313
12. Budge M.M., de Jager C., Hogervorst E., and Smith A.D. Oxford Project To Investigate Memory and Ageing (OPTIMA): Total plasma homocysteine, age, systolic blood pressure, and cognitive performance in older people. J. Am. Geriatr. Soc. 50 (2002) 2014-2018
13. Seshadri S., Beiser A., Selhub J., Jacques P.F., Rosenberg I.H., D'Agostino R.B., Wilson P.W., and Wolf P.A. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N. Engl. J. Med. 346 (2002) 476-483
14. Elias M.F., Sullivan L.M., D'Agostino R.B., Elias P.K., Jacques P.F., Selhub J., Seshadri S., Au R., Beiser A., and Wolf P.A. Homocysteine and cognitive performance in the Framingham offspring study: age is important. Am. J. Epidemiol. 162 (2005) 644-653
15. Darvesh S., Walsh R., Kumar R., Caines A., Roberts S., Magee D., Rockwood K., and Martin E. Inhibition of human cholinesterases by drugs used to treat Alzheimer disease. Alzheimer Dis. Assoc. Disord. 17 (2003) 117-126
16. Michaelis L., and Menten M.L. Die Kinetik der Invertinwirkung. Biochem. Z. 49 (1913) 333-369
17. Szegletes T., Mallender W.D., Thomas P.J., and Rosenberry T.L. Substrate binding to the peripheral site of acetylcholinesterase initiates enzymatic catalysis. Substrate inhibition arises as a secondary effect. Biochemistry 38 (1999) 122-133
18. Masson P., Xie W., Froment M.T., Levitsky V., Fortier P.L., Albaret C., and Lockridge O. Interaction between the peripheral site residues of human butyrylcholinesterase, D70 and Y332, in binding and hydrolysis of substrates. Biochim. Biophys. Acta 1433 (1999) 281-293
19. Eriksson H., and Augustinsson K.B. A mechanistic model for butyrylcholinesterase. Biochim. Biophys. Acta. 567 (1979) 161-173
20. Briggs G.E., and Haldane J.B. A Note on the Kinetics of Enzyme Action. Biochem. J. 19 (1925) 338-339
21. Botts J., and Morales M. Analytical description of the effects of modifiers and of enzyme multivalency upon the steady-state catalyzed reaction rate. Trans. Faraday Soc. 49 (1953) 696-707
22. Dixon M., and Webb E.C. Enzymes. 3rd ed. (1979), Academic Press, New York
23. Segel I.H. Enzyme Kinetics: Behavior and Analysis of Rapid Equilibrium and Steady-State Enzyme Systems (1993), John Wiley and Sons Inc, New York
24. Cornish-Bowden A. Fundamentals of Enzyme Kinetics (1995), Portland Press Ltd., London
25. Fontes R., Ribeiro J.M., and Sillero A. Inhibition and activation of enzymes. The effect of a modifier on the reaction rate and on kinetic parameters. Acta Biochim. Pol. 47 (2000) 233-257
26. Kruger-Thiemer E. Generalized kinetics of reversible inhibition and activation. Eur. J. Pharmacol. 6 (1969) 357-360
27. Russo S.F., and Moothart L. Kinetic Study of the Enzyme Lactase. J. Chem. Ed. 63 (1986) 242-243
28. Ellman G.L., Courtney K.D., Andres Jr. V., and Feather-Stone R.M. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem. Pharmacol. 7 (1961) 88-95
29. Copeland R.A. Enzymes. A practical introduction to structure, mechanism and data analysis (2000), Wiley-VCH Inc, New York
30. Fylstra D., Lasdon L., Watson J., and Waren A. Design and Use of the Microsoft Excel Solver. Interfaces 28 (1998) 29-55
31. Nenov I.P., and Fylstra D.H. Interval Methods for Accelerated Global Search in the Microsoft Excel Solver. Reliab. Comput. 9 (2003) 143-159
32. Li Y.K., and Byers L.D. Inhibition of beta-glucosidase by imidazoles. Biochim. Biophys. Acta 999 (1989) 227-232
33. Shinitzky M., Katchalski E., Grisaro V., and Sharon N. Inhibition of lysozyme by imidazole and indole derivatives. Arch. Biochem. Biophys. 116 (1966) 332-343
34. Field R.A., Haines A.H., Chrystal E.J., and Luszniak M.C. Histidines, histamines and imidazoles as glycosidase inhibitors. Biochem. J. 274 (1991) 885-999
35. Spears G., Sneyd J.G., and Loten E.G. A method for deriving kinetic constants for two enzymes acting on the same substrate. Biochem. J. 125 (1971) 1149-1151